rs797045993
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP2PP3PP5_Very_Strong
The NM_006306.4(SMC1A):c.2369G>A(p.Arg790Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_006306.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMC1A | ENST00000322213.9 | c.2369G>A | p.Arg790Gln | missense_variant | Exon 15 of 25 | 1 | NM_006306.4 | ENSP00000323421.3 | ||
SMC1A | ENST00000375340.10 | c.2303G>A | p.Arg768Gln | missense_variant | Exon 16 of 26 | 1 | ENSP00000364489.7 | |||
SMC1A | ENST00000675504.1 | c.2303G>A | p.Arg768Gln | missense_variant | Exon 15 of 25 | ENSP00000502524.1 | ||||
SMC1A | ENST00000674590.1 | c.1601G>A | p.Arg534Gln | missense_variant | Exon 13 of 23 | ENSP00000502626.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Congenital muscular hypertrophy-cerebral syndrome Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. This sequence change replaces arginine with glutamine at codon 790 of the SMC1A protein (p.Arg790Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is not present in population databases (rs797045993, ExAC no frequency). This variant has been reported as de novo in two individuals affected with Cornelia de Lange syndrome (PMID: 17273969, Invitae). ClinVar contains an entry for this variant (Variation ID: 212267). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. -
- -
SMC1A-related disorder Pathogenic:1
The SMC1A c.2369G>A variant is predicted to result in the amino acid substitution p.Arg790Gln. This variant was reported in individuals with Cornelia de Lange syndrome (Deardorff et al. 2007. PubMed ID: 17273969; Table 3, Pablo et al. 2021. PubMed ID: 34717699) and in a cohort of individuals with autism spectrum disorder (ASD, Supplementary Data 1, Zhou et al. 2022. PubMed ID: 35982159). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at